Symptoms unrelated to bleeding, such as fatigue and mental health struggles, are common among people with immune thrombocytopenia (ITP)…
Marisa Wexler MS
Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler MS
IMMUNE THROMBOCYTOPENIA
NewsScientists trace teenage boy’s ITP to mutation in ELF4 gene: Report
A mutation in the gene ELF4 likely set the stage for a teenage boy to develop immune thrombocytopenia (ITP), according…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsBrothers found to have rare mix of 2 genetic blood-clotting disorders
Two teenage brothers in Egypt have been diagnosed with an extremely rare combination of two distinct genetic blood-clotting disorders. The…
IMMUNE THROMBOCYTOPENIA
NewsTavalisse prepares to launch as treatment for ITP in Brazil, Mexico
Regulatory authorities in Brazil have approved the oral therapy Tavalisse (fostamatinib disodium hexahydrate)Â for…
IMMUNE THROMBOCYTOPENIA
NewsSYK inhibitors show promise as chronic primary ITP treatment option: Study
Spleen tyrosine kinase (SYK) inhibitors, including Tavalisse (fostamatinib disodium hexahydrate), may be effective treatments for…
VON WILLEBRAND DISEASE
Ruptured brain aneurysm in VWD patient treated with W-EB device
The case of a woman with von Willebrand disease type 1 who developed a ruptured brain aneurysm was described…
IMMUNE THROMBOCYTOPENIA
NewsGalapagos, Gilead discuss collaboration to develop gamgertamig
Pharma companies Galapagos and Gilead are in talks for a potential collaboration to develop gamgertamig, an experimental therapy…
VON WILLEBRAND DISEASE
NewsCelebrity-packed livestream to spotlight bleeding disorders
Celebrities and advocacy groups are teaming up to raise awareness of bleeding disorders with a three-hour livestream celebrating the community.
IMMUNE THROMBOCYTOPENIA
NewsNew care pathway improves treatment decisions for children with ITP
A group of U.S. treatment centers worked together to standardize care for children with immune thrombocytopenia (ITP), leading to…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsHidden HIV infection discovered following rare blood disorder relapse
A recent report describes the case of a woman with acquired thrombotic thrombocytopenic purpura (TTP) who was later found…